| 发明名称 |
USE OF AT-1 RECEPTOR ANTAGONIST OR AT-2 RECEPTOR MODULATOR FOR TREATING DISEASE ASSOCIATED WITH INCREASE OF AT-1 OR AT-2 RECEPTOR |
| 摘要 |
PROBLEM TO BE SOLVED: To provide use of an AT<SB>1</SB>receptor antagonist or an AT<SB>2</SB>receptor modulator, or a pharmaceutically acceptable salt thereof in production of pharmaceutical products for treatment of conditions or diseases associated with the increase of AT<SB>1</SB>receptors in the sub-epithelial area or increase of AT<SB>2</SB>receptors in the epithelia. SOLUTION: Tablets containing free base type valsartan and microcrystalline cellulose of≥30 wt.% based on the total weight of core ingredients are provided. COPYRIGHT: (C)2010,JPO&INPIT
|
| 申请公布号 |
JP2010090169(A) |
申请公布日期 |
2010.04.22 |
| 申请号 |
JP20100008140 |
申请日期 |
2010.01.18 |
| 申请人 |
NOVARTIS AG |
发明人 |
BULLOCK GILLIAN ROSEMARY;DE GASPARO MARC;GANTER SABINA MARIA |
| 分类号 |
A61K31/41;A61K9/20;A61K9/28;A61K31/00;A61K31/415;A61K31/4178;A61K31/4188;A61K31/437;A61K31/44;A61K31/4439;A61K31/455;A61K45/00;A61K47/32;A61K47/38;A61P1/18;A61P9/12;A61P11/00;A61P11/06;A61P11/16;A61P17/02;A61P35/00;A61P43/00;C07D257/04 |
主分类号 |
A61K31/41 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
